EACH YEAR IN THIS COUNTRY, 255-THOUSAND WOMEN WILL LEARN THAT THEY HAVE BREAST CANCER.  AND UNTIL THAT DIAGNOSIS, THEY MAY NOT REALIZE THAT BREAST CANCER IS NOT JUST ONE SINGLE DISEASE, BUT THAT THERE ARE MANY DIFFERENT TYPES. AS MANY AS 20{5e0bea7df62a42e70f4e6662baa016b718b42e41c3f575af4c98dbb1e2d44a4e} OF WOMEN HAVE THE MORE AGGRESSIVE FORM OF THE DISEASE, CALLED HER-2-POSITIVE BREAST CANCER.HERE TO EXPLAIN WHAT’S BEING DONE TO TREAT IT– AND HOPEFULLY KEEP IT FROM COMING BACK, ARE DR. DENISE YARDLEY, OF TENNESSEE ONCOLOGY, AND BREAST CANCER PATIENT ALLISON FIELDS. SUGGESTED QUESTIONS: DOCTOR – HOW MANY TYPES OF BREAST CANCER ARE THERE, AND WHY IS EARLY DIAGNOSIS SO IMPORTANT?   ALLISON – WHAT WAS IT LIKE BEING DIAGNOSED, AND HOW ARE YOU DOING TODAY?   DOCTOR – WHAT IS HER-TWO POSITIVE BREAST CANCER AND HOW IS IT TREATED?   ALLISON – WHAT ADVICE DO YOU HAVE FOR OTHER WOMEN FACING THIS DIAGNOSIS?   DOCTOR- WHERE CAN OUR VIEWERS LEARN MORE?   BIO: DENISE YARDLEY, MD Sarah Cannon Nashville, Tennessee Dr. Denise Yardley joined Sarah Cannon in 2000 as senior investigator of the breast cancer research program. In this role, she serves as principal investigator on numerous breast cancer clinical trials. Dr. Yardley received her undergraduate degree from Columbus State University in 1983 and her medical degree from the Medical College of Georgia in 1988. She completed her residency and fellowship training at the University of Texas Southwestern Medical Center in Dallas. A diplomate of the American Board of Internal Medicine, Medical Oncology and Hematology.

Skip to toolbar